Related Experiment Video
Updated: Nov 7, 2025

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
Published on: October 5, 2011
Transgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles
Megan A Yamoah1, Phung N Thai2, Xiao-Dong Zhang2,3
1Department of Economics, University of Oxford, Oxford OX1 3UQ, UK.
Nanoparticles offer a superior, non-viral method for delivering genetic material into human induced pluripotent stem cells (hiPSCs). This advanced nanotechnology overcomes challenges in hiPSC modification, enhancing regenerative medicine potential.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Nanotechnology
Background:
- Human induced pluripotent stem cells (hiPSCs) hold great promise for regenerative and precision medicine.
- Genetic modification of hiPSCs is crucial but faces significant transgene delivery challenges.
- Current viral and chemical methods can negatively impact hiPSC quality and function.
Purpose of the Study:
- To review the principles, applications, and significance of nanoparticle-mediated transgene delivery to hiPSCs.
- To highlight non-viral approaches as a necessary alternative to existing transfection methods.
- To discuss the potential of nanotechnology in advancing hiPSC research and applications.
Main Methods:
- Review of existing literature on nanoparticle applications in biomedicine and stem cell transfection.
- Analysis of nanoparticle-mediated transgene delivery advantages over conventional methods.
- Case study discussion of magnetic nanoparticles for hiPSC transfection.
Main Results:
- Nanoparticles provide an efficient, low-cytotoxicity, and cost-effective method for transgene delivery into hiPSCs.
- Nanoparticle-based approaches offer advantages like biodegradability and controlled delivery.
- Successful application of magnetic nanoparticles demonstrates their potential in hiPSC modification.
Conclusions:
- Nanotechnology presents a promising non-viral strategy for the genetic modification of hiPSCs.
- Nanoparticle-mediated delivery can overcome current limitations, improving hiPSC potency, purity, and safety.
- This approach supports the advancement of hiPSC applications in regenerative medicine and therapeutics, as exemplified by COVID-19 vaccine development.
More Related Videos
08:14Detection of Intracellular Gene Expression in Live Cells of Murine, Human and Porcine Origin Using Fluorescence-labeled Nanoparticles
Published on: November 13, 2015
09:03Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...